Emmaus Life Sciences Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2025 to a ratio of 5.09, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Emmaus Life Sciences Inc in Dec 31 2025 quarter, has decreased to 72 days, compared to 77 days, in the Jun 30 2025 quarter.

If we take a look into Healthcare sector 392 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2025 from 2560 to 2681.

What is Receivable Turnover Ratio?
What is Emmaus Life Sciences Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

EMMAW Receivables Turnover Ratio	(Dec 31 2025) IV. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter
Y / Y Receivable Change	-43.22 %	-54.96 %	-31.07 %	-52.52 %	7.65 %
Y / Y Revenue Change	-29.68 %	-47.61 %	-3.99 %	-54.04 %	9.17 %
Receivable Turnover Ratio (TTM)	5.09	4.72	4.6	4.34	4.45
EMMAW's Total Ranking	# 2681	# 2560	# 2739	# 2722	#
Accounts Receivable average collection period days	72	77	79	84	82
Seq. Receivable Change	35.39 %	0.49 %	-21.43 %	-46.88 %	7.39 %
Seq. Revenue Change	36.74 %	17.08 %	-22.16 %	-43.57 %	1.88 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 117
Healthcare Sector	# 393
Overall Market	# 2681

Receivable Turnover Ratio Statistics
High	Average	Low
25	11.27	2.82
(Dec 31 2020)		(Sep 30 2017)

EMMAW Company Profile • Back to EMMAW Efficiency Comparisons • Compare EMMAW Receivables Turnover Ratio to its Competitors

Financial Statements
Emmaus Life Sciences Inc 's Accounts Receivable	$ 3 Millions	Visit EMMAW's Balance sheet
Emmaus Life Sciences Inc 's Sales TTM	$ 12 Millions	Visit EMMAW's Income Statement
Sources of EMMAW's Revenues		Visit EMMAW's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
EMMAW's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
EMMAW's Growth Rates	EMMAW's Roa	EMMAW's Inventory Turnover Ratio	EMMAW's Dividend Comparisons
EMMAW's Profitability Ratios	EMMAW's Roi	EMMAW's Asset Turnover Ratio	EMMAW's Dividend Growth
EMMAW's Valuation Ratios	EMMAW's Roe	EMMAW's Financial Strength Ratios	EMMAW's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2025	Receivable at quarter ending Dec 31 2025
Ptc Therapeutics inc	11.92	$ 1,730.655 Millions	$ 145.207 Millions
Corcept Therapeutics Inc	11.91	$ 761.407 Millions	$ 63.950 Millions
Option Care Health Inc	11.86	$ 5,648.895 Millions	$ 476.492 Millions
Bioharvest Sciences Inc	11.83	$ 34.508 Millions	$ 2.916 Millions
Cytokinetics Incorporated	11.74	$ 88.039 Millions	$ 7.499 Millions
Teladoc Health Inc	11.74	$ 2,529.977 Millions	$ 215.496 Millions
Lifestance Health Group Inc	11.71	$ 1,424.285 Millions	$ 121.659 Millions
Chemed Corporation	11.65	$ 2,529.978 Millions	$ 217.224 Millions
Orthofix Medical Inc	11.58	$ 822.017 Millions	$ 71.016 Millions
Lucid Diagnostics Inc	11.57	$ 4.706 Millions	$ 0.407 Millions
Integrated Biopharma Inc	11.30	$ 51.068 Millions	$ 4.521 Millions
Nrc Health	11.28	$ 137.390 Millions	$ 12.176 Millions
Lftd Partners Inc	11.18	$ 36.921 Millions	$ 3.303 Millions
Petvivo Holdings Inc	11.10	$ 0.791 Millions	$ 0.071 Millions
Uniqure N v	10.98	$ 16.098 Millions	$ 1.466 Millions
National Healthcare Corp	10.92	$ 1,517.781 Millions	$ 138.939 Millions
Novavax inc	10.92	$ 1,123.479 Millions	$ 102.881 Millions
Vivos Therapeutics Inc	10.91	$ 16.542 Millions	$ 1.517 Millions
Cue Biopharma Inc	10.70	$ 27.466 Millions	$ 2.566 Millions
Inventiva S a	10.68	$ 13.898 Millions	$ 1.301 Millions
Lifeloc Technologies Inc	10.58	$ 9.027 Millions	$ 0.853 Millions
Exact Sciences Corporation	10.49	$ 3,245.310 Millions	$ 309.460 Millions
Bioaffinity Technologies Inc	10.37	$ 6.162 Millions	$ 0.594 Millions
Bioxcel Therapeutics Inc	10.27	$ 0.642 Millions	$ 0.063 Millions
Utah Medical Products Inc	10.25	$ 38.001 Millions	$ 3.706 Millions
Addus Homecare Corp	10.15	$ 1,421.874 Millions	$ 140.113 Millions
Biolife Solutions Inc	10.11	$ 96.118 Millions	$ 9.506 Millions
Scisparc Ltd	10.07	$ 0.856 Millions	$ 0.085 Millions
Aquestive Therapeutics Inc	10.03	$ 44.545 Millions	$ 4.441 Millions
Viemed Healthcare Inc	9.97	$ 270.280 Millions	$ 27.120 Millions

Date modified: 2026-09-08T15:11:39+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.